A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 262 participants.
Also called NCT01942070
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 262 participants
- Registry
-
NCT01942070
-
- Other papers using this trial's data
- Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Unknown status
Technical summary
Registry record NCT01942070. Randomized; no masking; primary purpose treatment. Start 2013-09 (actual); primary completion 2018-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction
- Acronym
- ISAR-Absorb MI
- Condition
- Cardiovascular Disease
- Condition
- Myocardial Infarction
- Condition
- Thrombus
- Condition
- Primary Angioplasty
- Intervention (Device)
- Bioresorbable vascular scaffold
- Intervention (Device)
- Durable polymer everolimus-eluting metallic stent
- Lead sponsor
- Deutsches Herzzentrum Muenchen
Record details
- Record id
cardio:ct-nct01942070- Content hash
da45e053b73d0ed485dcac5e6dc33edf8fef4746720c512c4f52474350c11989